The cellulase market has seen considerable growth due to a variety of factors.
• The cellulase market has experienced significant growth in recent years. It is expected to grow from $2.12 billion in 2024 to $2.32 billion in 2025, with a compound annual growth rate (CAGR) of 9.2%.
This growth can be attributed to the increasing demand from the pharmaceutical industry, the booming construction sector, the rise in biofuel consumption, the growing need for animal feed, and the higher production of wheat and other grains.
The cellulase market is expected to maintain its strong growth trajectory in upcoming years.
• The cellulase market is expected to grow to $3.26 billion by 2029 at a CAGR of 8.9%.
This growth is driven by the demand for food and beverage processing, the expansion of the paper industry, and the increasing use of cellulase in winemaking and the textile industry. Major trends include advancements in genetic engineering, industrial biotechnology, and enzyme production technologies, as well as innovations in textile processing and the development of eco-friendly products.
The rising demand for biofuels is expected to drive the cellulase market. Biofuels are renewable energy sources derived from organic materials. The shift toward biofuels is driven by the need for sustainable energy to reduce carbon emissions and reliance on fossil fuels. Cellulase helps convert cellulosic biomass into valuable fuels, aiding in the transition to renewable energy. According to the Energy Information Administration, U.S. biofuel production capacity grew by 7% in 2023, primarily driven by an increase in renewable diesel and other biofuels. This demand is propelling the cellulase market.
The cellulase market covered in this report is segmented –
1) By Type: Endoglucanase (EG), Cellobiohydrolase (CBH), Beta-Glucosidase (BG)
2) By Source: Fungi, Bacteria, Actinomycetes, Plants, Animals
3) By End Use: Healthcare, Industrial, Food And Beverages, Textile, Pulp And Paper
Subsegments:
1) By Endoglucanase (EG): Exoglucanase, Endo-1,4-Beta-Glucanase
2) By Cellobiohydrolase (CBH): Cellobiohydrolase I (CBHI), Cellobiohydrolase II (CBHII)
3) By Beta-Glucosidase (BG): Exoglucanase, Endoglucanase-Associated Beta-Glucosidase
In the cellulase market, companies are developing high-efficiency cellulase enzymes to improve industrial efficiency and sustainability. These enzymes break down cellulose into simpler sugars, enhancing processes in industries such as textiles, paper, and biofuels. For example, in May 2024, Canada-based Bionetix International launched ECL3000, a high-efficiency cellulase enzyme produced by non-pathogenic fungi. This enzyme targets cellulose in various products and benefits industries like textiles, paper, and biofuels.
Major companies operating in the cellulase market are:
• Archer Daniels Midland Company
• BASF SE
• Dow Inc.
• Merck KGaA
• Brenntag SE
• DuPont de Nemours Inc
• Koninklijke DSM N.V.
• Kerry Group plc
• Daicel Corporation
• Lenzing AG
• Novozymes BioAg Limited
• Ashland Inc
• Chr. Hansen Holding A/S
• Borregaard
• Kemin Industries Inc
• Genencor International Inc
• Amano Enzyme Inc
• Codexis Inc
• AB Enzymes GmbH
• MP Biomedicals LLC
• Biocatalysts Ltd
• BIO-CAT
• Worthington Biochemical Corporation
• Dyadic International Inc.
North America was the largest region in the cellulase market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cellulase market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.